
Satsuma Pharmaceuticals Announces U.S. FDA Approval For Atzumitm (Dihydroergotamine) Nasal Powder For The Acute ...
(MENAFN- PR Newswire) AtzumiTM (dihydroergotamine(DHE)) nasal powder is the first and only DHE nasal powder for the acute treatment of migraine with or without aura in adults in an easy-to-use, easy-to-carry device. Atzumi is the first and only product …